Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-046616
Filing Date
2022-08-18
Accepted
2022-08-18 16:17:29
Documents
1
Period of Report
2022-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6474
  Complete submission text file 0001209191-22-046616.txt   8502
Mailing Address 10 ORINDA VIEW ROAD ORINDA CA 94563
Business Address
FAIRBAIRN EMILY (Reporting) CIK: 0001682638 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39692 | Film No.: 221177685

Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10 ORINDA VIEW ROAD ORINDA CA 94563
Business Address 10 ORINDA VIEW ROAD ORINDA CA 94563 (646) 600-6438
Transcend Partners Opportunity Fund LLC (Reporting) CIK: 0001832019 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39692 | Film No.: 221177684